Clinical Trials

(Click  here for more information about the clinical trials available among members of the Regroupement des gynécologues oncologues du Québec. )

Open Trials

(Click the titles for more information)

1.  ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Identifier: NCT02855944

2. To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA) Identifier: NCT02476968

3.  A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherap (PRIMA) Identifier: NCT02655016

4.  An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma Identifier: NCT03257267

5.  Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas Identifier: NCT02503423

6.  AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors Identifier: NCT02511795

Clinical trials at the Gyn-Onc clinic are now available through the Rossy Cancer Network. Please click the following links for more information.


 Solid Tumors

More eligibility criteria may apply. Please contact Maryyam Azam at (514) 340 8222 x 24596 if interested.

Last updated: March 12, 2018

Page last updated on 

We always seek feedback to make our site better.